FEATURE
Funding Key to Growth of Scientific Innovations
March 7, 2010 | San Diego Union Tribune
Scuba divers harvesting the ocean floor for the next pharmaceutical breakthrough. Specially crafted molecules that guide surgeons to cancerous growths. Medical researchers studying sites such as Facebook to find early-warning signs of epidemics. Those were among the ideas that were discussed at the La Jolla Research & Innovation Summit last week, as a dozen scientists from some of the area’s top research centers unveiled their latest projects before more than 100 potential investors.
Read More
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It
March 5, 2010 | Xconomy
Research is the lifeblood of the biotech and pharmaceuticals business. The pharma and biotech industry spent some $65 billion dollars on R & D in 2008, according to the Pharmaceutical Research and Manufacturers Association. The numbers suggest that drug makers need to find a more efficient way of developing medicines.
Read More
Public Pension Funds Are Adding Risk to Raise Returns
March 9, 2010 | New York Times
States and companies have started investing very differently when it comes to the billions of dollars they are safeguarding for workers’ retirement. Companies are quietly and gradually moving their pension funds out of stocks. But states and other bodies of government are seeking higher returns for their pension funds. Higher returns come with more risk.
Read More
How Obama's Team Hopes to Fix Patent Office
March 3, 2010 | San Jose Mercury News
Back in August 2006, Facebook founder Mark Zuckerberg and a handful of employees submitted paperwork to patent the social network's "news feed." Last week, they got their patent. Predictably, the awarding of the patent sent the Web's chattering classes into a tizzy, debating its merits and the implications for social-networking competitors who have adopted their own version of the news feed.
Read More
|
|
|